Erenumab (AMG 334) in episodic migraine: Interim analysis of an ongoing open-label study

Messoud Ashina*, David Dodick, Peter J. Goadsby, Uwe Reuter, Stephen Silberstein, Feng Zhang, Julia R. Gage, Sunfa Cheng, Daniel D. Mikol, Robert A. Lenz

*Corresponding author for this work
86 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Erenumab (AMG 334) in episodic migraine: Interim analysis of an ongoing open-label study'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science